Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silva Markovic-Plese

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Oncotarget|October 10, 2015
IL-11 in multiple sclerosisXin Zhang, Tracy Putoczki, Silva Markovic-Plese
Frontiers in Rehabilitation Sciences|October 3, 2022
Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot StudyPrudence Plummer, Silva Markovic-Plese, Barbara Giesser
Neurology|June 3, 2009
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosisSilva Markovic-Plese, Valerie Jewells, Danielle Speer
Future Neurology|January 29, 2010
Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepairSilva Markovic-Plese, Avtar K Singh, Inderjit Singh
Trends in Molecular Medicine|July 13, 2012
Pathogenic features of CD4+CD28- T cells in immune disordersBieke Broux, Silva Markovic-Plese, Piet Stinissen, et al.
Archives of Neurology|April 13, 2005
Acute disseminated encephalomyelitis after liver transplantationEric Lindzen, Ajmal Gilani, Silva Markovic-Plese, et al.
Journal of Clinical & Cellular Immunology|December 24, 2013
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple SclerosisMark S Freedman, Johanne M Kaplan, Silva Markovic-Plese
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2011
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosisXin Zhang, Yazhong Tao, Luigi Troiani, et al.
Clinical Immunology (Orlando, Fla.)|January 18, 2015
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosisKevin Blauth, Xin Zhang, Manisha Chopra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytesXin Zhang, Jianping Jin, Xueyan Peng, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Oncotarget|October 10, 2015
IL-11 in multiple sclerosisXin Zhang, Tracy Putoczki, Silva Markovic-Plese
Frontiers in Rehabilitation Sciences|October 3, 2022
Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot StudyPrudence Plummer, Silva Markovic-Plese, Barbara Giesser
Neurology|June 3, 2009
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosisSilva Markovic-Plese, Valerie Jewells, Danielle Speer
Future Neurology|January 29, 2010
Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepairSilva Markovic-Plese, Avtar K Singh, Inderjit Singh
Trends in Molecular Medicine|July 13, 2012
Pathogenic features of CD4+CD28- T cells in immune disordersBieke Broux, Silva Markovic-Plese, Piet Stinissen, et al.
Archives of Neurology|April 13, 2005
Acute disseminated encephalomyelitis after liver transplantationEric Lindzen, Ajmal Gilani, Silva Markovic-Plese, et al.
Journal of Clinical & Cellular Immunology|December 24, 2013
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple SclerosisMark S Freedman, Johanne M Kaplan, Silva Markovic-Plese
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2011
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosisXin Zhang, Yazhong Tao, Luigi Troiani, et al.
Clinical Immunology (Orlando, Fla.)|January 18, 2015
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosisKevin Blauth, Xin Zhang, Manisha Chopra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytesXin Zhang, Jianping Jin, Xueyan Peng, et al.
Pageof 6